532330 — Biopac India Income Statement
0.000.00%
Basic MaterialsMicro Cap
Annual income statement for Biopac India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 521 | 478 | 472 | 202 | 49.1 |
Cost of Revenue | |||||
Gross Profit | 244 | 252 | 235 | 12.3 | -14.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 475 | 432 | 454 | 389 | 129 |
Operating Profit | 46 | 45.4 | 18.4 | -186 | -79.7 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7.48 | 2.8 | -30.2 | -231 | -116 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.519 | 0.983 | -27 | -231 | -111 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.519 | 0.983 | -27 | -231 | -111 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.519 | 0.983 | -27 | -231 | -111 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.03 | 0.057 | -1.57 | -13.4 | -7.33 |